Scharnagl H - Search Results

1

NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study.

Rudolf H, Mügge A, Trampisch HJ, Scharnagl H, März W, Kara K. Rudolf H, et al. Among authors: scharnagl h. Int J Cardiol Heart Vasc. 2020 Jun 5;29:100553. doi: 10.1016/j.ijcha.2020.100553. eCollection 2020 Aug. Int J Cardiol Heart Vasc. 2020. PMID: 32529024 Free PMC article.

2

A novel assay for cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase activity using reversed-phase ion-pair chromatography: demonstration that Lifibrol (K12.148) modulates the enzyme activity.

Scharnagl H, März W, Schliack M, Löser R, Gross W. Scharnagl H, et al. J Lipid Res. 1995 Mar;36(3):622-7. J Lipid Res. 1995. PMID: 7775873 Free article.

3

Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.

Durovic S, März W, Frank S, Scharnagl H, Baumstark MW, Zechner R, Kostner GM. Durovic S, et al. Among authors: scharnagl h. J Biol Chem. 1994 Dec 2;269(48):30320-5. J Biol Chem. 1994. PMID: 7982944 Free article.

4

Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation.

März W, Scharnagl H, Kirça M, Bohl J, Gross W, Ohm TG. März W, et al. Among authors: scharnagl h. Ann N Y Acad Sci. 1996 Jan 17;777:276-80. doi: 10.1111/j.1749-6632.1996.tb34432.x. Ann N Y Acad Sci. 1996. PMID: 8624098

5

Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.

Feussner G, Scharnagl H, Scherbaum C, Acar J, Dobmeyer J, Lohrmann J, Wieland H, März W. Feussner G, et al. Among authors: scharnagl h. J Lipid Res. 1996 Aug;37(8):1632-45. J Lipid Res. 1996. PMID: 8864947 Free article.

6

Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis.

Winkler K, Scharnagl H, Tisljar U, Hoschützky H, Friedrich I, Hoffmann MM, Hüttinger M, Wieland H, März W. Winkler K, et al. Among authors: scharnagl h. J Lipid Res. 1999 Mar;40(3):447-55. J Lipid Res. 1999. PMID: 10064733 Free article.

7

Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements.

Gierens H, Nauck M, Roth M, Schinker R, Schürmann C, Scharnagl H, Neuhaus G, Wieland H, März W. Gierens H, et al. Among authors: scharnagl h. Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1777-83. doi: 10.1161/01.atv.20.7.1777. Arterioscler Thromb Vasc Biol. 2000. PMID: 10894816

8

Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia.

Hoffmann MM, Scharnagl H, Köster W, Winkler K, Wieland H, März W. Hoffmann MM, et al. Among authors: scharnagl h. Clin Chim Acta. 2001 Jan;303(1-2):41-8. doi: 10.1016/s0009-8981(00)00372-7. Clin Chim Acta. 2001. PMID: 11163021

9

Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.

Hoffmann MM, Scharnagl H, Panagiotou E, Banghard WT, Wieland H, März W. Hoffmann MM, et al. Among authors: scharnagl h. J Am Soc Nephrol. 2001 Mar;12(3):524-530. doi: 10.1681/ASN.V123524. J Am Soc Nephrol. 2001. PMID: 11181800

10

Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia.

Nauck MS, Köster W, Dörfer K, Eckes J, Scharnagl H, Gierens H, Nissen H, Nauck MA, Wieland H, März W. Nauck MS, et al. Among authors: scharnagl h. Hum Mutat. 2001 Aug;18(2):165-6. doi: 10.1002/humu.1171. Hum Mutat. 2001. PMID: 11462246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters